Cuba registers new skin cancer medicine

Posted on Posted in news

Cuba has registered a new skin cancer medicine called “Heberferon” developed by the island’s Genetic Engineering and Biotechnology Center (CIGB) After 20 years of research and clinical trials, Cuba’s Havana-based Genetic Engineering and Biotechnology Center (CIGB) has developed a new medicine called “Heberferon.” BiologistIraldo Bello, who participated in the process, described the drug which combines interferón “Alfa” and interferón “Gamma” through the use of recombinant technology at the CIGB – as “unique” in the world. The injectable medication cures or reduces the size of malignant skin tumors and can prevent scaring from surgery in areas difficult to operate on such […]